ONE-YEAR EFFECTIVENESS, RETENTION RATE AND SAFETY OF SECUKINUMAB IN ANKYLOSING SPONDYLITIS AND PSORIATIC ARTHRITIS: A REAL-LIFE MULTICENTRE STUDY

被引：1
|
作者：
Chimenti, M. S. [1 ]
Fonti, G. L. [1 ]
Conigliaro, P. [1 ]
Sunzini, F. [1 ]
Scrivo, R. [2 ]
Navarini, L. [3 ]
Triggianese, P. [1 ]
Peluso, G. [4 ]
Scolieri, P. [5 ]
Caccavale, R. [6 ]
Picchianti-Diamanti, A. [7 ]
De Martino, E. [1 ]
Salemi, S. [7 ]
Birra, D. [4 ]
Altobelli, A. [2 ]
Paroli, M. [6 ]
Bruzzese, V. [5 ]
Lagana, B. [7 ]
Gremese, E. [4 ]
Conti, F. [2 ]
Afeltra, A. [3 ]
Perricone, R. [1 ]
机构：
[1] Univ Roma Tor Vergata, Rheumatol Allergol & Clin Immunol, Rome, Italy
[2] Sapienza Univ Roma, Reumatol, Dipartimento Med Interna & Specialita Med, Rome, Italy
[3] Univ Campus Biomed Roma, Dept Med, Unit Allergol Immunol & Rheumatol, Rome, Italy
[4] Univ Cattolica Sacro Cuore, Fdn Policlin Univ Agostino Gemelli, IRCCS Presidio Columbus, Ist Reumatol & Sci Affini, Rome, Italy
[5] Osped Nuovo Regina Margherita, UOC Med Interna & Reumatol, Rome, Italy
[6] Sapienza Univ Roma, Dipartimento Sci & Biotecnol Med Chirurg, Latina, Italy
[7] Sapienza Univ Rome, St Andrea Univ Hosp, Dept Clin & Mol Med, Rome, Italy
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2020年 / 79卷
关键词：
D O I：
10.1136/annrheumdis-2020-eular.3777
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
FRI0270
引用
收藏
页码：716 / 716
页数：1
相关论文
共 50 条
  • [31] One Dose Risankizumab Effectiveness in Psoriasis: A Real-Life Multicentre Study
    Magdaleno-Tapial, Jorge
    Ortiz-Salvador, Jose Maria
    Santos-Alarcon, Sergio
    Belinchon-Romero, Isabel
    Sahuquillo-Torralba, Antonio
    Gonzalez-Delgado, Victor
    Sabater-Abad, Javier
    Armengot-Carbo, Miquel
    Mari-Ruiz, Juan Ignacio
    Mateu-Puchades, Almudena
    Mataix-Diaz, Javier
    Schneller-Pavelescu, Luca
    Carmena-Ramon, Rafael
    Martorell, Antonio
    Sanchez-Carazo, Jose Luis
    DERMATOLOGIC THERAPY, 2024, 2024
  • [32] Real-Life Effectiveness of Infliximab in the Treatment of Ankylosing Spondylitis: The Canadian Experience
    Rahinan, Proton
    Sampalis, John
    Khalil, Hayssam
    JOURNAL OF RHEUMATOLOGY, 2010, 37 (06) : 1276 - 1276
  • [33] Certolizumab Pegol Effectiveness and Retention Rate in Psoriatic Arthritis. Real Life Data
    Conesa, Arantxa
    Fernandez, Manuel
    Exposito, Rosa
    Campos, Jose
    Ramon Lamua, Jose
    del Pilar Navarro, Maria
    Rubio-Munoz, Paula
    Ahijado-Guzman, Pilar
    Gonzalez, Carlos M.
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [34] Effectiveness of Adalimumab for the Treatment of Psoriatic Arthritis: An Italian Real-Life Retrospective Study
    D'Angelo, Salvatore
    Cantini, Fabrizio
    Ramonda, Roberta
    Cantarini, Luca
    Carletto, Antonio
    Chimenti, Maria Sole
    Delle Sedie, Andrea
    Foti, Rosario
    Gerli, Roberto
    Lomater, Claudia
    Lubrano, Ennio
    Marchesoni, Antonio
    Zabotti, Alen
    Salvarani, Carlo
    Scrivo, Rossana
    Scarpa, Raffaele
    Tramontano, Giuseppina
    Nannini, Carlotta
    Lorenzin, Mariagrazia
    Fabbroni, Marta
    Martinis, Federica
    Perricone, Roberto
    Carli, Linda
    Visalli, Elisa
    Rovera, Guido
    Perrotta, Fabio Massimo
    Quartuccio, Luca
    Altobelli, Alessio
    Costa, Luisa
    Niccoli, Laura
    Ortolan, Augusta
    Caso, Francesco
    FRONTIERS IN PHARMACOLOGY, 2019, 10
  • [35] The effectiveness of a real life dose reduction strategy for tumour necrosis factor inhibitors in ankylosing spondylitis and psoriatic arthritis
    Fong, Warren
    Holroyd, Chris
    Davidson, Brian
    Armstrong, Ray
    Harvey, Nick
    Dennison, Elaine
    Cooper, Cyrus
    Edwards, Christopher J.
    RHEUMATOLOGY, 2016, 55 (10) : 1837 - 1842
  • [36] Levetiracetam One Year Retention Rate in Real-Life Paediatric Practice in France, the EULEVp Study
    Dureau, C.
    Droz, C.
    Pedespan, J. M.
    Lavernhe, G.
    Mann, M.
    Jove, J.
    Moore, N.
    Fourrier, A.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2009, 18 : S140 - S141
  • [37] Drug Survival, Safety, and Effectiveness of Secukinumab for up to 5 Years in Patients with Psoriasis and Psoriatic Arthritis: A Long-Term Real-Life Experience
    Mastorino, Luca
    Dapavo, Paolo
    Cariti, Caterina
    Susca, Sara
    Siliquini, Niccolo
    Ortoncelli, Michela
    Stroppiana, Elena
    Verrone, Anna
    di Corteranzo, Isotta Giunipero
    Leo, Francesco
    Quaglino, Pietro
    Ribero, Simone
    JOURNAL OF PERSONALIZED MEDICINE, 2024, 14 (07):
  • [38] Real-life effectiveness and safety of secukinumab in axial spondyloarthritis: a single-center study
    Sun Yuankai
    Wang Jiajia
    Qiu Yulu
    Lin Shiyu
    Wang Fang
    Tan Wenfeng
    中华医学杂志(英文版), 2022, 135 (21)
  • [39] Real-life effectiveness and safety of secukinumab in axial spondyloarthritis: a single-center study
    Sun, Yuankai
    Wang, Jiajia
    Qiu, Yulu
    Lin, Shiyu
    Wang, Fang
    Tan, Wenfeng
    CHINESE MEDICAL JOURNAL, 2022, 135 (21) : 2623 - 2624
  • [40] Secukinumab Drug Survival in Psoriasis and Psoriatic Arthritis Patients: A 24-Month Real-Life Study
    Ortolan, Augusta
    Lorenzin, Mariagrazia
    Leo, Giovanni
    Pampaloni, Francesca
    Messina, Francesco
    Doria, Andrea
    Piaserico, Stefano
    Ramonda, Roberta
    DERMATOLOGY, 2022, 238 (05) : 897 - 903
12345